Found: 35
Select item for more details and to access through your institution.
Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state C.G. Fanelli et al.: Rate of fall of postprandial blood glucose and responses to hypoglycaemia in Type I diabetes
- Published in:
- Diabetologia, 2003, v. 46, n. 1, p. 53, doi. 10.1007/s00125-002-0948-9
- By:
- Publication type:
- Article
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 6, p. 789, doi. 10.1007/s00592-021-01675-0
- By:
- Publication type:
- Article
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 3, p. 251, doi. 10.1111/j.1463-1326.2010.01343.x
- By:
- Publication type:
- Article
Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1).
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 2, p. 176, doi. 10.1111/dme.12328
- By:
- Publication type:
- Article
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
- Published in:
- Diabetic Medicine, 2006, v. 23, n. 2, p. 141, doi. 10.1111/j.1464-5491.2005.01738.x
- By:
- Publication type:
- Article
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
- Published in:
- Diabetic Medicine, 2004, v. 21, n. 11, p. 1213, doi. 10.1111/j.1464-5491.2004.01323.x
- By:
- Publication type:
- Article
Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin.
- Published in:
- Diabetic Medicine, 2002, v. 19, n. 11, p. 917, doi. 10.1046/j.1464-5491.2002.00830.x
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 366, doi. 10.1111/dom.12618
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 375, doi. 10.1111/dom.12619
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial ( EDITION JP 2).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 366, doi. 10.1111/dom.12618
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial ( EDITION JP 1).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 375, doi. 10.1111/dom.12619
- By:
- Publication type:
- Article
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1142, doi. 10.1111/dom.12532
- By:
- Publication type:
- Article
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 835, doi. 10.1111/dom.12472
- By:
- Publication type:
- Article
Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 859, doi. 10.1111/dom.12485
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 386, doi. 10.1111/dom.12438
- By:
- Publication type:
- Article
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 1, p. 15, doi. 10.1111/dom.12329
- By:
- Publication type:
- Article
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 7, p. 588, doi. 10.1111/dom.12253
- By:
- Publication type:
- Article
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 2, p. 170, doi. 10.1111/dom.12192
- By:
- Publication type:
- Article
Demonstration of a dawn phenomenon in normal human volunteers.
- Published in:
- 1984
- By:
- Publication type:
- journal article
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.
- Published in:
- 1984
- By:
- Publication type:
- journal article
The Dawn Phenomenon: Nocturnal Blood Glucose Homeostasis in Insulin-dependent Diabetes Mellitus.
- Published in:
- Diabetic Medicine, 1988, v. 5, n. 1, p. 13, doi. 10.1111/j.1464-5491.1988.tb00934.x
- By:
- Publication type:
- Article
Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Diabetes and breast cancer risk: a meta-analysis.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 9, p. 1608, doi. 10.1038/bjc.2012.414
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Contribution of amino acids and insulin to protein anabolism during meal absorption.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Effects of recent, short-term hyperglycemia on responses to hypoglycemia in humans. Relevance to the pathogenesis of hypoglycemia unawareness and hyperglycemia-induced insulin resistance.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Hypoglycemia in IDDM.
- Published in:
- 1989
- By:
- Publication type:
- journal article